Lipocine Ownership | Who Owns Lipocine?
Lipocine Ownership Summary
Lipocine is owned by 8.49% institutional investors, 2.84% insiders, and 88.67% retail investors. Vanguard group is the largest institutional shareholder, holding 4.10% of LPCN shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.64% of its assets in Lipocine shares.
LPCN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Lipocine | 8.49% | 2.84% | 88.67% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 221.87K | 4.10% | $1.78M |
| Blackrock funding, inc. /de | 89.27K | 1.65% | $716.85K |
| Geode capital management | 62.45K | 1.15% | $501.54K |
| Renaissance | 37.40K | 0.69% | $300.30K |
| State street | 18.63K | 0.35% | $53.27K |
| Northern trust | 13.16K | 0.25% | $37.51K |
| Dimensional fund advisors lp | 12.14K | 0.22% | $97.48K |
| Jane street group | 10.57K | 0.20% | $84.91K |
| Ubs group | 5.60K | 0.10% | $44.99K |
| Advisor group | 2.27K | 0.04% | $6.46K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Caldwell sutter capital | 471.00 | 0.00% | $3.78K |
| Renaissance | 37.40K | 0.00% | $300.30K |
| Highmark wealth management | 100.00 | 0.00% | $803.00 |
| Tower research capital llc (trc) | 1.17K | 0.00% | $3.33K |
| Tidemark | 59.00 | 0.00% | $474.00 |
| Jane street group | 10.57K | - | $84.91K |
| Advisor group | 2.27K | - | $6.46K |
| Northern trust | 13.16K | - | $37.51K |
| Barclays | - | - | - |
| Geode capital management | 62.45K | - | $501.54K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Jane street group | 10.57K | - | 10.57K |
| Ubs group | 5.60K | - | 3.84K |
| Geode capital management | 62.45K | - | 1.37K |
| Renaissance | 37.40K | 0.00% | 1.30K |
| Tower research capital llc (trc) | 1.17K | 0.00% | 497.00 |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Barclays | - | - | -9.41K |
| Advisor group | 2.27K | - | -19.00 |
| Jpmorgan chase | - | - | -11.00 |
| Citigroup | - | - | -3.00 |
| Tidemark | 59.00 | 0.00% | - |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Jane street group | 10.57K | - | 10.57K | $84.91K |
| Highmark wealth management | 100.00 | 0.00% | 100.00 | $803.00 |
Sold Out
| Holder | Change |
|---|---|
| Citigroup | -3.00 |
| Jpmorgan chase | -11.00 |
| Barclays | -9.41K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 14 | -33.33% | 459,539 | -13.18% | 8 | 8.68% | 6 | -14.29% | - | -100.00% |
| Sep 30, 2025 | 21 | 16.67% | 529,307 | 0.16% | 9 | 10.14% | 7 | 16.67% | 4 | -33.33% |
| Jun 30, 2025 | 18 | -5.26% | 528,356 | 2.10% | 9 | 10.55% | 5 | -54.55% | 7 | 133.33% |
| Mar 31, 2025 | 19 | 11.76% | 517,473 | 6.33% | 9 | 11.64% | 11 | 120.00% | 3 | -25.00% |
| Dec 31, 2024 | 17 | -5.56% | 486,671 | -10.62% | 9 | 8.79% | 5 | -50.00% | 4 | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 141.08K | 2.64% | - |
| Vanguard Total Stock Mkt Idx Inv | 142.77K | 2.57% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 57.90K | 1.04% | 6.86K |
| Fidelity Extended Market Index | 28.82K | 0.52% | -56.00 |
| Vifag 2002 SICAV | 17.77K | 0.33% | - |
| Blackrock Extended Mkt Fund CF | 14.75K | 0.27% | 14.75K |
| BlackRock Extended Equity Market K | 12.86K | 0.24% | -5.00 |
| Extended Equity Market Fund K | 12.65K | 0.23% | 8.00 |
| Fidelity Total Market Index | 8.69K | 0.16% | - |
| Spartan Extended Market Index Pool F | 8.52K | 0.15% | 56.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 25, 2023 | Patel Mahesh V. | CEO and President | Buy | $43.79K |
| Mar 24, 2023 | Patel Mahesh V. | CEO and President | Buy | $48.00K |
| Mar 20, 2023 | Ono Richard Dana | - | Buy | $1.36K |
| Mar 17, 2023 | Patel Mahesh V. | CEO and President | Buy | $16.50K |
| Nov 22, 2022 | Papapetropoulos Spyros | - | Buy | $10.22K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | - | - |
| 2024 Q2 | - | - |
LPCN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools